Safranal has demonstrated anti-inflammatory effects on OVA-induced airway inflammation via modulation of type 1 and 2 helper T lymphocytes balance, evident from the reduced serum IL-4 and elevated IFNγ (Boskabady et al., 2014). Here, IFNG is linked to inflammatory response.